FERRITIN IN THE CEREBROSPINAL FLUID PREDICTS RATE OF AMYLOID BETA ACCUMULATION IN BIOMARKER-CONFIRMED ALZHEIMER'S DISEASE

被引：0
|
作者：
Ayton, Scott [1 ]
Diouf, Ibrahima [2 ]
Bush, Ashley [1 ,3 ,4 ]
机构：
[1] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia
[2] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
[3] Univ Melbourne, Brisbane, Qld, Australia
[4] Cooperat Res Ctr Mental Hlth, Parkville, Vic, Australia
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2017年 / 92卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LB16
引用
收藏
页码：E466 / E466
页数：1
相关论文
共 50 条
  • [1] β-amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer's disease
    Andreasen, N
    Blennow, K
    [J]. PEPTIDES, 2002, 23 (07) : 1205 - 1214
  • [2] Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum
    Putcha, Deepti
    Dickerson, Bradford C.
    Brickhouse, Michael
    Johnson, Keith A.
    Sperling, Reisa A.
    Papp, Kathryn, V
    [J]. NEUROPSYCHOLOGIA, 2020, 140
  • [3] The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease
    Wang-Dietrich, Lei
    Funke, Susanne Aileen
    Kuehbach, Katja
    Wang, Kun
    Besmehn, Astrid
    Willbold, Sabine
    Cinar, Yeliz
    Bannach, Oliver
    Birkmann, Eva
    Willbold, Dieter
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (04) : 985 - 994
  • [4] Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
    Holtta, Mikko
    Hansson, Oskar
    Andreasson, Ulf
    Hertze, Joakim
    Minthon, Lennart
    Nagga, Katarina
    Andreasen, Niels
    Zetterberg, Henrik
    Blennow, Kaj
    [J]. PLOS ONE, 2013, 8 (06):
  • [5] Cerebrospinal fluid amyloid beta and tau protein: biomarkers for Alzheimer's disease
    Mandic, Gorana
    Markovic, Ivanka
    Ostojic, Marija
    Stojkovic, Tanja
    Misirlic-Dencic, Sonja
    Zivanovic-Radnic, Tatjana
    Stefanovic, Rodoljub
    Bumbasirevic, Marko
    Stefanova, Elka
    Kostic, Vladimir
    [J]. VOJNOSANITETSKI PREGLED, 2008, 65 (12) : 901 - 905
  • [6] Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
    Palmqvist, Sebastian
    Insel, Philip S.
    Stomrud, Erik
    Janelidze, Shorena
    Zetterberg, Henrik
    Brix, Britta
    Eichenlaub, Udo
    Dage, Jeffrey L.
    Chai, Xiyun
    Blennow, Kaj
    Mattsson, Niklas
    Hansson, Oskar
    [J]. EMBO MOLECULAR MEDICINE, 2019, 11 (12)
  • [7] Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's disease
    Desai, Urvi
    Gomes, Dumingu Aparna
    Chandler, Julie
    Ye, Wenyu
    Daly, Michael
    Kirson, Noam
    Dennehy, Ellen B.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2024,
  • [8] Cerebrospinal Fluid Biomarker for Alzheimer Disease Predicts Postoperative Cognitive Dysfunction
    Evered, Lisbeth
    Silbert, Brendan
    Scott, David A.
    Ames, David
    Maruff, Paul
    Blennow, Kaj
    [J]. ANESTHESIOLOGY, 2016, 124 (02) : 353 - 361
  • [9] Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta
    John S. K. Kauwe
    Jun Wang
    Kevin Mayo
    John C. Morris
    Anne M. Fagan
    David M. Holtzman
    Alison M. Goate
    [J]. neurogenetics, 2009, 10 : 13 - 17
  • [10] Assessment of amyloid beta protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease
    Southwick, PC
    Yamagata, SK
    Echols, CL
    Higson, GJ
    Neynaber, SA
    Parson, RE
    Munroe, WA
    [J]. JOURNAL OF NEUROCHEMISTRY, 1996, 66 (01) : 259 - 265
12345